Novo Nordisk Reports 47% Year-on-Year Increase in First Nine Months' Net Profit for 2023

Danish pharmaceutical company Novo Nordisk released its financial report for the first nine months of 2023. The report shows that in the first three quarters, Novo Nordisk's net sales reached 166.398 billion Danish kroner, a year-on-year increase of 29%; net profit was 61.720 billion Danish kroner, a year-on-year increase of 47%. (Jiemian)Original link